Poster Abstract Session:
142. HIV: Prevention
Friday, October 5, 2018: 12:30 PM-1:45 PM
Room: S Poster Hall

Tracks: Adult ID, Epidemiology and Infection Control, HIV-STD-TB, Investigative ID, Pediatric ID


Presentations:
Seizing Opportunities for Intervention: Changing HIV Knowledge among Men Who Have Sex with Men and Transgender Women Attending Trusted Community Centers in Nigeria
Milissa Jones, MD; Habib Omari, MD; Sylvia Adebajo, MD, PhD; Charlotte Gaydos, DrPH, MS; Afoke Kokogho, MD; Stefan Baral, PhD; Rebecca Nowak, PhD; Julie Ake, MD, MSc; Manhattan Charurat, PhD; Merlin L. Robb, MD; Trevor A. Crowell, MD, PhD
Adolescents' Knowledge and Acceptance of Pre-exposure Prophylaxis (PrEP) in the Capital District Region of New York
Roberto P. Santos, MD, MSc; Mary Ellen Adams, ACRN; Martha Lepow, MD; Debra Tristram, MD
A Model for “At-Distance” PrEP Navigation: Acceptability and Early Insights
Jacob Perlson, BS; Blake Kruger, BS; Sravanthi Padullaparti, MPP, MS; Elizabeth Eccles, MS, RN; Tim Lahey, MD, MMSc
Posters
  • 1290_IDWPOSTER FINAL.pdf (3.1 MB)
  • HIV Pre-Exposure Prophylaxis (PrEP) Implementation at Silom Community Clinic in Bangkok, Thailand, 2016-2018
    Vanessa Kung, PhD; Sarika Pattanasin, DrPH, MSc; Chaiwat Ungsedhapand, MD; Wipas Wimonsate, MRP, MSc; Michael Thigpen, MD, DTM&H, FIDSA; Eileen Dunne, MD, MPH, FIDSA
    The Next Step in PrEP: Evaluating Outcomes of a Pharmacist-Run HIV Pre-Exposure Prophylaxis (PrEP) Clinic
    Keenan Ryan, PharmD, PhC; Jessica Lewis, BS Biology/Psychology; Daniel Sanchez, BS; Beverly Anderson, BA; Renee-Claude Mercier, PharmD
    Acceptability and Feasibility of a Pharmacist-led Pre-exposure Prophylaxis Program in the Midwestern United States
    Sara Bares, MD; Joshua Havens, PharmD; Kimberly Scarsi, PharmD; Donald Klepser, PhD, MBA; Susan Swindells, MBBS
    Posters
  • FINAL P-PrEP IDWeek 2018.pdf (1010.5 kB)
  • Advancing the PrEP Continuum: A Novel Collaboration between a Public Health Department and a Federally Qualified Health Care Center in the Southern United States
    Meredith Clement, MD; Cedar Eagle, BA; Destry Taylor, BA; Benjamin Goldstein, PhD; Barbara Johnston, MD; Arlene Sena, MD, MPH
    Posters
  • IDweek.9-10.MEC_AS.final.pdf (257.2 kB)
  • Potential use of Sexually Transmitted Infection (STI) Testing for Expanding HIV Pre-Exposure Prophylaxis (PrEP) at an Urban Hospital Center
    Robert Pitts, MD; Robert Holzman, MD, FIDSA, FSHEA; Richard Greene, MD; Emily Lam, BS; Ellie Carmody, MD, MPH; Scott Braithwaite, MD
    Posters
  • id week.pdf (1017.8 kB)
  • Characteristics for PrEP uptake, retention, and discontinuation: data from the ANCHOR study
    Poonam Mathur, DO, MPH; Sarah Kattakuzhy, MD; Laura Nussdorf, BS; Kristi Hill, BS; Rachel Silk, BSN, MPH; Chloe Gross, RN, BSN, ACRN; Elizabeth Akoth, RN; Nadeera Sidique, BS; Chloe Chaudhury, BS; David Sternberg, BA; Henry Masur, MD, FIDSA; Shyam Kottilil, MD, PhD; Elana Rosenthal, MD
    Acquisition of TDF-susceptible HIV Despite High Level Adherence to Daily TDF/FTC PrEP as Measured by Dried Blood Spot (DBS) and Segmental Hair Analysis: A Case Report
    Stephanie E. Cohen, MD, MPH; Darpun Sachdev, MD; Sulggi Lee, MD, PhD; Susan Scheer, PhD MPH; Oliver Bacon, MD, MPH; Miao-Jung Chen, PhD, MPH; Clarissa Ospina Norvell, FNP; Hideaki Okochi, PhD; Peter Anderson, PharmD; Susa Coffey, MD; Hyman Scott, MD; Diane Havlir, MD, FIDSA; Monica Gandhi, MD, MPH
    Posters
  • Cohen_IDWeek Poster_Final.pdf (916.3 kB)
  • Iowa TelePrEP: Preliminary Experience with a Public Health-Partnered, Telemedical PrEP Delivery Model in a Rural State
    Angela Hoth, PharmD MPH; Cody Shafer, EIS/PrEP Coordinator; Dena Dillon, PharmD AAHIVP; Constanza Scheetz, Health Educator; Seth Owens, Health Educator; Kathryn Edel, Health Educator; Michael Ohl, MD MSPH
    Posters
  • 1299 Iowa TelePrEP Poster.pdf (385.4 kB)
  • Young Heterosexual Men in Rural South Africa Want Access to PrEP
    Alisse Hannaford, BS; Bulelani Khoza, NSC; Anthony P Moll, MBChB; Sheela V Shenoi, MD, MPH

    CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™


    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.